Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II.

Trial Profile

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs Argatroban (Primary) ; Danaparoid sodium (Primary) ; Fondaparinux sodium (Primary) ; Lepirudin (Primary)
  • Indications Embolism and thrombosis; Heparin-induced thrombocytopenia and thrombosis syndrome
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 28 Nov 2017 Results published in the Journal of the American College of Cardiology
    • 04 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top